Analyst Price Target is GBX 46.50
▲ +21.34% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Life Science REIT in the last 3 months. The average price target is GBX 46.50, with a high forecast of GBX 57 and a low forecast of GBX 36. The average price target represents a 21.34% upside from the last price of GBX 38.32.
Current Consensus is
Moderate Buy
The current consensus among 3 contributing investment analysts is to moderate buy stock in Life Science REIT. This rating has held steady since August 2024, when it changed from a Buy consensus rating.